Vitiligo Therapeutics Market
Vitiligo is a long-term skin condition characterized by patches of the skin losing their pigment. ... Read More
Sexually transmitted diseases (STD), are infections that are commonly spread by sexual activity. Many times STD initially do not cause symptoms, this results in a greater risk of passing the disease on to others.
This report contains market size and forecasts of Sexually Transmitted Diseases (STD) Treatment in Global, including the following market information:
Global Sexually Transmitted Diseases (STD) Treatment Market Revenue, 2017-2022, 2023-2028, ($ millions)
Global top five companies in 2021 (%)
The global Sexually Transmitted Diseases (STD) Treatment market was valued at million in 2021 and is projected to reach US$ million by 2028, at a CAGR of % during the forecast period.
The U.S. Market is Estimated at $ Million in 2021, While China is Forecast to Reach $ Million by 2028.
Viral Infections Segment to Reach $ Million by 2028, with a % CAGR in next six years.
The global key manufacturers of Sexually Transmitted Diseases (STD) Treatment include Pfizer, Roche, Gilead Sciences, GlaxoSmithKline, Johnson & Johnson, Merck, AbbVie, Bayer and Bristol-Myers Squibb and etc. In 2021, the global top five players have a share approximately % in terms of revenue.
MARKET MONITOR GLOBAL, INC (MMG) has surveyed the Sexually Transmitted Diseases (STD) Treatment companies, and industry experts on this industry, involving the revenue, demand, product type, recent developments and plans, industry trends, drivers, challenges, obstacles, and potential risks.
Total Market by Segment:
Global Sexually Transmitted Diseases (STD) Treatment Market, by Type, 2017-2022, 2023-2028 ($ millions)
Global Sexually Transmitted Diseases (STD) Treatment Market Segment Percentages, by Type, 2021 (%)
Viral Infections
Bacterial Infections
Others
Global Sexually Transmitted Diseases (STD) Treatment Market, by Application, 2017-2022, 2023-2028 ($ millions)
Global Sexually Transmitted Diseases (STD) Treatment Market Segment Percentages, by Application, 2021 (%)
Hospitals
Clinics
Others
Global Sexually Transmitted Diseases (STD) Treatment Market, By Region and Country, 2017-2022, 2023-2028 ($ Millions)
Global Sexually Transmitted Diseases (STD) Treatment Market Segment Percentages, By Region and Country, 2021 (%)
North America
US
Canada
Mexico
Europe
Germany
France
U.K.
Italy
Russia
Nordic Countries
Benelux
Rest of Europe
Asia
China
Japan
South Korea
Southeast Asia
India
Rest of Asia
South America
Brazil
Argentina
Rest of South America
Middle East & Africa
Turkey
Israel
Saudi Arabia
UAE
Rest of Middle East & Africa
Competitor Analysis
The report also provides analysis of leading market participants including:
Key companies Sexually Transmitted Diseases (STD) Treatment revenues in global market, 2017-2022 (estimated), ($ millions)
Key companies Sexually Transmitted Diseases (STD) Treatment revenues share in global market, 2021 (%)
Further, the report presents profiles of competitors in the market, key players include:
Pfizer
Roche
Gilead Sciences
GlaxoSmithKline
Johnson & Johnson
Merck
AbbVie
Bayer
Bristol-Myers Squibb
Eli Lilly
Vitiligo is a long-term skin condition characterized by patches of the skin losing their pigment. ... Read More
Heart valve repair is a surgical technique used to fix defects in heart valves in valvular heart ... Read More
Gene Therapy is an experimental treatment that involves introducing genetic material into a perso ... Read More
Diabetic neuropathies are nerve damaging disorders associated with diabetes mellitus. These condi ... Read More